GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aytu BioPharma Inc (STU:AY20) » Definitions » Change In Inventory

Aytu BioPharma (STU:AY20) Change In Inventory : €-0.13 Mil (TTM As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Aytu BioPharma Change In Inventory?

Aytu BioPharma's change in inventory for the quarter that ended in Dec. 2024 was €0.60 Mil. It means Aytu BioPharma's inventory declined by €0.60 Mil from Sep. 2024 to Dec. 2024 .

Aytu BioPharma's change in inventory for the fiscal year that ended in Jun. 2024 was €-2.70 Mil. It means Aytu BioPharma's inventory increased by €2.70 Mil from Jun. 2023 to Jun. 2024 .

Aytu BioPharma's Total Inventories for the quarter that ended in Dec. 2024 was €10.59 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Aytu BioPharma's Days Inventory for the quarter that ended in Dec. 2024 was 186.04.

Inventory Turnover measures how fast the company turns over its inventory within a year. Aytu BioPharma's Inventory Turnover for the quarter that ended in Dec. 2024 was 0.49.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Aytu BioPharma's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.68.


Aytu BioPharma Change In Inventory Historical Data

The historical data trend for Aytu BioPharma's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aytu BioPharma Change In Inventory Chart

Aytu BioPharma Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.30 2.31 1.23 -3.33 -2.70

Aytu BioPharma Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.63 0.12 -1.15 0.30 0.60

Aytu BioPharma Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aytu BioPharma  (STU:AY20) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Aytu BioPharma's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=10.5815/5.19*365 / 4
=186.04

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Aytu BioPharma's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Aytu BioPharma's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aytu BioPharma Change In Inventory Related Terms

Thank you for viewing the detailed overview of Aytu BioPharma's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Aytu BioPharma Business Description

Traded in Other Exchanges
Address
7900 East Union Avenue, Suite 920, Denver, CO, USA, 80237
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

Aytu BioPharma Headlines

No Headlines